[go: up one dir, main page]

AU2017900495A0 - Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases - Google Patents

Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases

Info

Publication number
AU2017900495A0
AU2017900495A0 AU2017900495A AU2017900495A AU2017900495A0 AU 2017900495 A0 AU2017900495 A0 AU 2017900495A0 AU 2017900495 A AU2017900495 A AU 2017900495A AU 2017900495 A AU2017900495 A AU 2017900495A AU 2017900495 A0 AU2017900495 A0 AU 2017900495A0
Authority
AU
Australia
Prior art keywords
cannabinoids
dermatitis
formulations
treatment
skin diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017900495A
Inventor
Matthew CALLAHAN
Eugene Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Inc
Original Assignee
Botanix Pharmaceuticals Inc
Filing date
Publication date
Application filed by Botanix Pharmaceuticals Inc filed Critical Botanix Pharmaceuticals Inc
Publication of AU2017900495A0 publication Critical patent/AU2017900495A0/en
Priority to PCT/AU2018/050044 priority Critical patent/WO2018148785A1/en
Priority to EP18754514.0A priority patent/EP3582768A4/en
Priority to US16/486,290 priority patent/US20210401768A1/en
Priority to CA3053500A priority patent/CA3053500A1/en
Priority to AU2018221880A priority patent/AU2018221880B2/en
Priority to JP2019544865A priority patent/JP7012089B2/en
Priority to CN201880023264.5A priority patent/CN110545807B/en
Priority to IL268720A priority patent/IL268720B2/en
Priority to BR112019017018A priority patent/BR112019017018A2/en
Priority to JP2022005183A priority patent/JP2022050641A/en
Abandoned legal-status Critical Current

Links

AU2017900495A 2017-02-15 2017-02-15 Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases Abandoned AU2017900495A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
BR112019017018A BR112019017018A2 (en) 2017-02-15 2018-01-24 cannabinoid formulations for the treatment of dermatitis and inflammatory skin diseases
AU2018221880A AU2018221880B2 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
EP18754514.0A EP3582768A4 (en) 2017-02-15 2018-01-24 CANNABINOID FORMULATIONS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES
US16/486,290 US20210401768A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
CA3053500A CA3053500A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
PCT/AU2018/050044 WO2018148785A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
JP2019544865A JP7012089B2 (en) 2017-02-15 2018-01-24 Preparation of cannabinoids for the treatment of dermatitis and inflammatory bowel disease
CN201880023264.5A CN110545807B (en) 2017-02-15 2018-01-24 Cannabinoid preparations for the treatment of dermatitis and inflammatory skin diseases
IL268720A IL268720B2 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
JP2022005183A JP2022050641A (en) 2017-02-15 2022-01-17 Formulations of cannabinoids for treatment of dermatitis and inflammatory skin diseases

Publications (1)

Publication Number Publication Date
AU2017900495A0 true AU2017900495A0 (en) 2017-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
IL268720A (en) Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
EP3270938A4 (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
SMT202000305T1 (en) Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3169321A4 (en) Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3258908A4 (en) Compositions and methods for treatment of skin infections
CA3266235A1 (en) Compositions and methods for the treatment of skin diseases
EP3154637A4 (en) Treatment of virus-based diseases of the skin
SMT202100070T1 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases
EP3554494A4 (en) Compositions and methods for the treatment of inflammation
EP3386516A4 (en) Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
AU2017900495A0 (en) Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases
EP3500591A4 (en) Compositions and methods for treatment of bone associated diseases
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
HK40092382A (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
HK40093809A (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EP3272349A4 (en) Therapeutic and/or prophylactic agent for lewy body diseases
HK1262725A1 (en) Combination treatment of ocular inflammatory disorders and diseases
EP3616687B8 (en) Preparation for the treatment and/or prophylaxis of inflammatory infectious diseases
HK40040367A (en) Compositions and methods relating to the treatment of diseases
AU2017901730A0 (en) Compositions for the Treatment of Diseases and Conditions
HK40029560A (en) Methods and medical uses relating to the treatment of hypoglycaemia